Patent applications and USPTO patent grants for YUROGEN BIOSYSTEMS LLC.The latest application filed is for "monoclonal antibody against spike s1 protein of sars-cov-2 and use thereofof".
Patent | Date |
---|---|
MONOCLONAL ANTIBODIES AGAINST SARS-CoV-2 NUCLEOCAPSID PROTEIN AND USES THEREOF App 20220056112 - WU; Hai ;   et al. | 2022-02-24 |
MONOCLONAL ANTIBODY AGAINST SPIKE S1 PROTEIN OF SARS-CoV-2 AND USE THEREOFOF App 20220056111 - WU; Hai ;   et al. | 2022-02-24 |
Monoclonal Antibodies Against Human Pd-l1 And Uses Thereof App 20200386770 - LOU; Yang ;   et al. | 2020-12-10 |
NCAGE Code | 7HBW4 | YUROGEN BIOSYSTEMS LLC |
CAGE Code | 7HBW4 | YUROGEN BIOSYSTEMS LLC |
DUNS | 080047779 | YUROGEN BIOSYSTEMS LLC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.